Fuller & Thaler Asset Management
IMDZ

Fuller & Thaler Asset Management’s Immune Design Corp. IMDZ Stock Holding History

Fuller & Thaler Asset Management’s Portfolio IMDZ Stock Details IMDZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-12,100
Closed -$243K – 950
2015
Q4 		$243K Buy
+12,100
New +$208K 0.01% 359

Other funds holding IMDZ

PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Fuller & Thaler Asset Management's IMDZ Position: Q1 2016 in Review

Fuller & Thaler Asset Management sold out of Immune Design Corp. (IMDZ) in Q1 2016, closing a stake of 12,100 shares — an estimated $243K sold.

Fuller & Thaler Asset Management first reported a position in IMDZ in Q4 2015 and held it in 1 quarter. The position peaked at $243K in Q4 2015. 59 funds tracked by Wall St. Rank hold IMDZ as of Q1 2016.

  • Fuller & Thaler Asset Management reported no remaining Immune Design Corp. position as of Q1 2016 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 12,100 Immune Design Corp. shares in Q1 2016, an estimated $243K.
  • Fuller & Thaler Asset Management first reported a position in Immune Design Corp. in Q4 2015 and held it in 1 quarter.
  • Fuller & Thaler Asset Management's Immune Design Corp. position peaked at $243K in Q4 2015.
  • 59 funds tracked by Wall St. Rank held Immune Design Corp. as of Q1 2016.

Based on Fuller & Thaler Asset Management's 13F filing for Q1 2016, filed 12 May 2016.